• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVyera Pharmaceuticals

Vyera Pharmaceuticals

Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
HealthMartin Shkreli’s Lawyer Sentenced to 18 Months in Prison
By David Z. MorrisAugust 18, 2018
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli’s Lawyer Will Probably Join Him in Prison
By David Z. MorrisDecember 27, 2017
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
TechMartin Shkreli is Getting Into Magic: the Gathering, and Gamers Are Conflicted
By David Z. MorrisJuly 10, 2016
Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
HealthMartin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
By Sy MukherjeeJuly 1, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthMartin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike
By Sy MukherjeeMarch 17, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
FinanceThis Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
Arts & EntertainmentMartin Shkreli Just Got Sued Over His $2 Million Wu-Tang Clan Album
By ReutersFebruary 9, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthHow Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
APTOPIX Shkreli Arrest
HealthMartin Shkreli Gets the Okay to Face a Congressional Grilling
By ReutersJanuary 25, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
LeadershipMartin Shkreli Asks Court to Consider Blocking Subpoena
By ReutersJanuary 23, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli Is Headed For a Major Showdown With Congress
By ReutersJanuary 22, 2016
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
FinanceHere’s How Much Martin Shkreli Is Actually Worth
By Jen WiecznerJanuary 8, 2016
<> at Downsview Park on September 20, 2015 in Toronto, Canada.
Arts & EntertainmentWu-Tang’s RZA Says He Doesn’t Care What Martin Shkreli Does with His Album
By Laura LorenzettiJanuary 6, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
FinanceMartin Shkreli’s Replacement Has a Questionable Past
By Dan PrimackDecember 21, 2015
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Energy
Markets shudder as Strait of Hormuz starts resembling a combat zone. 'We're prepared to subject you to disabling fire'placeholder alt text
By Jason MaApril 19, 2026
AI
Thousands of CEOs admit AI had no impact on employment or productivity—and it has economists resurrecting a paradox from 40 years agoplaceholder alt text
By Sasha RogelbergApril 19, 2026
Economy
The explosion of U.S. debt is wiping out the 'safety premium' of Treasury bonds, and time is running out for an orderly fiscal solution, IMF warnsplaceholder alt text
By Jason MaApril 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.